Such discrepancy between our results and published ones in other papers, indicates that it is still unclear either increased or decreased CCL-17 level is a characteristic for AD patients, however its distinct level when compared to the control groups testifies its role in AD pathogenesis. This evidence concerns the gene CCL17 and Alzheimer disease.